Triumph Capital Management’s Amgen AMGN Stock Holding History

Triumph Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$595K	Sell	1,644 -3	-0.2%	-$1.03K	0.11%	192
2026 Q1	$579K	Buy	1,647 +87	+6%	+$31K	0.12%	167
2025 Q4	$511K	Buy	1,560 +17	+1%	+$5.39K	0.11%	168
2025 Q3	$435K	Buy	1,543 +569	+58%	+$165K	0.12%	187
2025 Q2	$272K	Buy	+974	New	+$276K	0.08%	239
2022 Q1	–	Sell	-2,776	Closed	-$625K	–	200
2021 Q4	$625K	Sell	2,776 -101	-4%	-$21.3K	0.27%	89
2021 Q3	$612K	Buy	2,877 +315	+12%	+$72.5K	0.29%	93
2021 Q2	$627K	Buy	+2,562	New	+$630K	0.37%	67

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Triumph Capital Management's AMGN Position: Q2 2026 in Review

Triumph Capital Management reduced its Amgen (AMGN) stake by 0.18% in Q2 2026, selling an estimated $1.03K and leaving 1,644 shares worth $595K. The position accounts for 0.11% of the portfolio, ranked #192.

Triumph Capital Management first reported a position in AMGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $627K in Q2 2021. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Triumph Capital Management held 1,644 shares of Amgen worth $595K as of Q2 2026.
Triumph Capital Management sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
Amgen made up 0.11% of Triumph Capital Management's portfolio in Q2 2026, its #192 holding.
Triumph Capital Management first reported a position in Amgen in Q2 2021 and has held it in 8 quarters since.
Triumph Capital Management's Amgen position peaked at $627K in Q2 2021.
1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.